Shortages of antiseizure medications in Australia and the association with patient switching, and adherence in a community setting
暂无分享,去创建一个
[1] E. Trinka,et al. Recommendations for treatment strategies in people with epilepsy during times of shortage of antiseizure medications , 2022, Epileptic disorders : international epilepsy journal with videotape.
[2] E. Beghi,et al. Appropriate use of generic and branded antiseizure medications in epilepsy: Updated recommendations from the Italian League Against Epilepsy (LICE) , 2021, Epilepsy & Behavior.
[3] J. Greene,et al. The Pandemic and the Supply Chain: Gaps in Pharmaceutical Production and Distribution. , 2021, American journal of public health.
[4] LG Chem-Neste signed a strategic partnership agreement. , 2021, Focus on Catalysts.
[5] C. Anderson,et al. Assuming one dose per day yields a similar estimate of medication adherence in patients with stroke: An exploratory analysis using linked registry data , 2020, British journal of clinical pharmacology.
[6] Mark S. Daskin,et al. Incentivizing resilient supply chain design to prevent drug shortages: policy analysis using two- and multi-stage stochastic programs , 2019, IISE Trans..
[7] B. Godman,et al. Medicine Shortages: Gaps Between Countries and Global Perspectives , 2019, Front. Pharmacol..
[8] H. Hamer,et al. Switching the manufacturer of antiepileptic drugs is associated with higher risk of seizures: A nationwide study of prescription data in Germany , 2018, Annals of neurology.
[9] W. Theodore,et al. Generic antiepileptic drugs—Safe or harmful in patients with epilepsy? , 2018, Epilepsia.
[10] Aziz Sheikh,et al. What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature , 2018, BMJ Open.
[11] N. Jetté,et al. A longitudinal cohort study on the impact of the clobazam shortage on patients with epilepsy , 2018, Epilepsia.
[12] J. Pines,et al. Shortage of generic neurologic therapeutics , 2017, Neurology.
[13] P. Kwan,et al. Association between switching antiepileptic drug products and healthcare utilization: A systematic review , 2017, Epilepsy & Behavior.
[14] H. Hamer,et al. Nonadherence to antiepileptic drugs in Germany , 2016, Neurology.
[15] D. Vossler,et al. AES Position Statement on Generic Substitution of Antiepileptic Drugs , 2016, Epilepsy currents.
[16] M. Cockeran,et al. Medicine possession ratio as proxy for adherence to antiepileptic drugs: prevalence, associations, and cost implications , 2016, Patient preference and adherence.
[17] D. Kaski,et al. Advances in the diagnosis and management of epilepsy in adults , 2015 .
[18] S. Sullivan,et al. Bioequivalent antiepileptic drug switching and the risk of seizure-related events , 2013, Epilepsy Research.
[19] William H Shrank,et al. Variations in pill appearance of antiepileptic drugs and the risk of nonadherence. , 2013, JAMA internal medicine.
[20] S‐M Huang,et al. Drug Shortages in the United States: A Critical Evaluation of Root Causes and the Need for Action , 2013, Clinical pharmacology and therapeutics.
[21] C. L. Ventola,et al. The drug shortage crisis in the United States: causes, impact, and management strategies. , 2011, P & T : a peer-reviewed journal for formulary management.
[22] K. Rascati,et al. Effects of Antiepileptic Drug Substitutions on Epileptic Events Requiring Acute Care , 2009, Pharmacotherapy.
[23] Brien Smith,et al. Case‐control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes , 2009, Epilepsia.
[24] J. LeLorier,et al. Clinical consequences of generic substitution of lamotrigine for patients with epilepsy , 2008, Neurology.
[25] K. Chan,et al. Methods for evaluation of medication adherence and persistence using automated databases , 2006, Pharmacoepidemiology and drug safety.
[26] Thomas J. Johnson. Drug shortages: an increasing problem for patients and clinicians. , 2011, South Dakota medicine : the journal of the South Dakota State Medical Association.